from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1073/-

LFCtreatmentdescriptionclass of inhibitor

0.000

Amikacinug/mL Amikacintranslation

-0.311

Cap5-10ug/mL Capreomycintranslation

-0.435

Rox10-50 ug/mL Roxithromycintranslation

0.000

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

-0.325

Rif0.2-5ug/mL Rifampicintranscription

-0.251

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.257

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.124

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.907

CPZ10-50 ug/mL Chlorpromazinerespiration

0.828

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.380

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.064

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.742

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.024

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.176

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.633

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.151

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.571

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.530

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.388

KCN5-20 ug/mL Potassium cyaniderespiration

-0.878

NaN30.2-2 mM Sodium aziderespiration

0.421

Nigericin50 uM Nigericinrespiration

-0.289

TRC10-150 ug/mL Triclosanrespiration

1.409

TRZ10-25 ug/mL Thioridazinerespiration

2.417

Valinomycin0.5-10 uM Valinomycinrespiration

0.147

ZnSO42 mM ZnSO4respiration

1.721

menadione6-10 ug/mL Menadionerespiration

-0.860

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.531

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.624

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.686

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.146

NRP_1Non-replicating persistence stage 1dosRassociated

0.000

Amp0.2mg/mL AmpicillincellWall

0.118

Cephalexin20-100 ug/mL CephalexincellWall

-0.580

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.360

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.285

EMB10-20 ug/mL EthambutolcellWall

0.000

Eta12-40 ug/mL EthionamidecellWall

0.000

INH0.2-0.4 ug/mL IsoniazidcellWall

0.000

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.800

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.277

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.396

BZA0.12 mg/mL BenzamidearomaticAmides

-0.484

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.056

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.206

H2O24 mM hydrogen peroxideDNAdamaging

0.000

Levo10 ug/mL LevofloxacinDNAdamaging

-0.106

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.575

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.000

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.226

UVUV-irradiationDNAdamaging

0.613

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.718

Antimycin12.5-50 ug/mL Antimycin A?

-0.581

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.356

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.013

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.892

PA8240.2-2 ug/mL PA-824?

-0.066

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.429

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.240

Verapamil50 uM Verapamil?

-0.700

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.569

methoxatin10-20 ug/mL Methoxatin?